3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
16
Neoplasms
14
Prostatic Neoplasms
10
Hematologic Neoplasms
9
Colorectal Neoplasms
8
Lung Neoplasms
5
Hematopoietic and Lymphatic System Neoplasm
5
Squamous Cell Carcinoma of Head and Neck
4
Anatomic Stage I Breast Cancer AJCC v8
4
Triple Negative Breast Neoplasms
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Mouth Neoplasms
3
Melanoma
3
Malignant Solid Neoplasm
3
Leukemia, Myeloid, Acute
3
Head and Neck Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Urinary Bladder Neoplasms
2
Sarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Parotid Neoplasms
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Head and Neck Carcinoma
2
Glioma
2
Carcinoma, Squamous Cell
2
Carcinoma, Renal Cell
2
Carcinoma, Basal Cell
2
COVID-19
2
Interventions
Letrozole
4
Fulvestrant
4
trastuzumab deruxtecan
2
toripalimab
2
elacestrant
2
Injections
2
Anastrozole
2
AZD9833
2
ribociclib
1
palbociclib
1
exemestane
1
disitamab vedotin
1
abemaciclib
1
Selective Estrogen Receptor Modulators
1
Ritonavir
1
RAD1901
1
Paclitaxel
1
Lead
1
Itraconazole
1
Goserelin
1
Gonadotropin-Releasing Hormone
1
Everolimus
1
Alpelisib
1
AZD5305
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Breast Cancer
×
Standard of Care
×
90 days
×
Clear all
No trials found.